SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mad2 who wrote (807)8/28/1999 1:00:00 PM
From: out_of_the_loop  Read Replies (2) of 5582
 
<<Unfortunatly the products GUMM plans on selling require inventory, stock and receivables and are a bit more capital intensive (not to mention seasonal with the associated risks>>>

I asked how long it would take to produce a large initial international order of nic gum. The answer: Running 3 shifts day - 3 days to a week. Running one shift a day - 3 weeks. The big capital has been already laid out - the production and warehousing capacities, as previously mentioned, have been already doubled - and I saw them in person.

Zicam inventories are not as much as a problem per se with GUMM/GelTech insofar as having the companies set up their warehouse-->store distribution. They will "get their sh*t together" when the publicity hits, IMO because it will be customer-driven.

Your words of caution are always in order and well-taken. Perhaps a compromise between my "unbridled optimism" and your "this company has only a 5% chance" is about where the truth lies. Indeed, time will tell and most of the people who follow this company closely believe that "time" is between now and this coming Jan-Feb.

Regards,

Howard
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext